பிரிவு போல்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரிவு போல்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரிவு போல்ட் Today - Breaking & Trending Today

Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

<div class="at-above-post addthis tool" data-url="https://www.metro.us/switzerland-unfortunately-still-awaiting/"></div>ZURICH (Reuters) – Switzerland’s drug regulator is still awaiting data needed to consider whether to approve AstraZeneca’s COVID-19 vaccine, a Swissmedic official said on Tuesday, adding the information “unfortunately” had yet to be submitted. AstraZeneca was the first vaccine maker to seek Swiss approval in early October 2020, but has since been overtaken by three […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https:// ....

United States , United Kingdom , John Revill , Silke Koltrowitz , John Miller , Nora Kronig , Claus Bolte , European Union , Drug Administration , Latin America , North America , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஜான் மில்லர் , பிரிவு போல்ட் , ஐரோப்பிய தொழிற்சங்கம் , லத்தீன் அமெரிக்கா , வடக்கு அமெரிக்கா ,

Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data &#x2013; official


By Syndicated Content
Apr 20, 2021 7:47 AM
ZURICH (Reuters) - Switzerland s drug regulator is still awaiting data needed to consider AstraZeneca s COVID-19 vaccine candidate for approval, a Swissmedic official said on Tuesday, adding the information unfortunately has yet to be submitted.
We re waiting, just like the U.S. Food and Drug Administration, for the results of clinical trials in Latin America and North America, Claus Bolte, Swissmedic s head of approvals said at a virtual press conference from Bern. It was announced four weeks ago, but it has unfortunately not yet been submitted.
(Reporting by John Miller, editing by John Revill)
);
}
return false; ....

United States , John Revill , John Miller , Claus Bolte , Drug Administration , Latin America , North America , ஒன்றுபட்டது மாநிலங்களில் , ஜான் மில்லர் , பிரிவு போல்ட் , லத்தீன் அமெரிக்கா , வடக்கு அமெரிக்கா ,

Coronavirus latest news: Community transmission now the key to lifting lockdown, insists Sage scientist


Coronavirus latest news: UK getting safer every day as almost 1 in 5 adults have had first vaccine, says Nadhim Zahawi
Read full article
Oops!
The UK is getting safer every day as almost one in five adults have now had their first dose of the coronavirus vaccine, Nadhim Zahawi has said.
The NHS is on track to meet its target of vaccinating the top four priority groups by mid-February through a close focus on the most vulnerable , the vaccines minister told MPs.
More than nine in 10 people over the age of 80 have now had their first dose of the vaccine, as have nine in 10 over-75s and over half of all over-70s. ....

United States , United Kingdom , South Africa , City Of , Greater Manchester , United Kingdom General , Saudi Arabia , Brighton And Hove , North Korea , Stoke Newington , South African , Rob Paterson , Jonathan Van Tam , Andrew Hayward , Aimee Murton , Claus Bolte , Priti Patel , Tom Moore , Simon Stevens , Vaughan Gething , Boris Johnson , Matt Hancock , Astrazeneca Oxford Covid , Matthew Snape , Nadhim Zahawi , Oxford Astrazeneca ,

Vaccines minister declines to say when over-50s will receive a Covid-19 jab


The vaccines minister has declined to put a date on when all over-50s can expect to receive a Covid-19 jab but figures suggest late March may be an option if supplies continue.
Nadhim Zahawi said a target would be set for reaching all those aged 50 to 70, as well as those with underlying conditions which put them at higher risk of serious disease, once the most vulnerable have been offered a jab by February 15.
Previously, NHS England chief executive Sir Simon Stevens has said the aim is for all over-50s and those at risk to be vaccinated by the end of April. ....

United Kingdom , South Africa , United States , Matt Hancock , Andrew Hayward , Jonathan Van Tam , Nadhim Zahawi , Claus Bolte , Chris Whitty , Yvette Cooper , Simon Stevens , Home Affairs Select Committee , Scientific Advisory Group For Emergencies Sage , Oxford University Astrazeneca , Sir Simon Stevens , Prime Minister , Professor Chris Whitty , Downing Street , Professor Andrew Hayward , Scientific Advisory Group , Health Secretary Matt Hancock , South America , Professor Jonathan Van Tam , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , மேட் ஹான்காக் ,